barr might too, i read some of the IP surronding the generics and all these companies appear to make a generic equivalent even though it may be covered under patent, apply for a marketing license, then sue the companies that hold the patent for invalidity and the companies counter sue for infringment. seems a nasty game
Market Data 
Markets 
AI
